Just wanting to clarify the market size of respiratory diagnosis. Many people are referring to 700M as the market size, this is only an estimation by the OECD of the number respiratory consultations which lead to an actual diagnosis.
There is a likely another 700M consultations which do not result in a diagnosis whereby ResApp could be used - so infact the market size is close to 1.4B per year. This was made clear by Dr Tony during the Gold Coast presentation.
Also another role has opened up, it looks like RAP are hiring for someone to take on domestic responsibilities - this is another very positive move and will only free up top level management to further push ahead.
